XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
SCHEDULE OF STOCK OPTION

A summary of the stock option activity under the Company’s incentive plan for the three months ended March 31, 2024 is presented below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding at December 31, 2023   30,329   $57.17   $77.22    3.4   $ 
Granted      $   $          
Forfeited   (4,493)  $44.25   $71.63          
Outstanding at March 31, 2024   25,836   $59.42   $78.20    3.1   $ 
                          
Exercisable at March 31, 2024   24,586   $62.29   $82.04    2.8   $ 
SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY

The Company’s activity in restricted stock units was as follows for the three months ended March 31, 2024:

 

   Number of
shares
   Weighted average
fair value
 
Non-vested at December 31, 2023   140,491   $28.97 
Granted   251,500   $0.85 
Forfeited   (9,729)  $2.87 
Vested   (26,146)  $2.62 
Non-vested at March 31, 2024   356,116   $11.76 
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

 

Stock-based compensation expense for RSUs:  2024   2023 
   Three Months Ended March 31, 
Stock-based compensation expense for RSUs:  2024   2023 
         
General and administrative  $152,429   $252,315 
Research and development   205,741    232,434 
Total  $358,170   $484,749 
SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at March 31, 2024:

 

   Warrant shares outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   2,799,213   $11.79    4.6   $ 
Exercised   (1,954,000)   1.37       $ 
Outstanding at March 31, 2024   845,213   $35.87    3.4   $ 
                     
Exercisable at March 31, 2024   845,213   $35.87    3.4   $ 
SCHEDULE OF WARRANTS AND INVESTMENT OPTIONS

The following table summarizes information about investment options outstanding at March 31, 2024:

 

   Investment options outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   70,000   $10.00    4.1   $ 
Outstanding at March 31, 2024   70,000   $10.00    3.3   $ 
                     
Exercisable at March 31, 2024   70,000   $10.00    3.3   $